
ARISTOCRAT: A randomised controlled phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma
For copies of the latest and previous versions of documents distributed for this trial, please contact the ARISTOCRAT Trial Office.
Please note: This trial is no longer recruiting patients. We hope to add results when they are available.
Overview of ARISTOCRAT trial
| Chief Investigator: |
Dr Fiona Collinson |
| Sponsor: |
University of Birmingham |
| Funder: |
The Brain Tumour Charity |
| Disease Site: |
Glioblastoma |
| Trial Type: |
Clinical Trial of an Investigational Medicinal Product |
| Status: |
Active - Not Recruiting |
| EudraCT Number: |
2021-005214-34 |
| IRAS Number: |
1004427 |
| Recruitment Start Date: |
03-Feb-2023 |
| Recruitment End Date: |
07-Oct-2026 |
| ClinicalTrials.gov Number: |
NCT05629702 |
| ISRCTN Number: |
11460478 |
| CRCTU Trial Management Team: |
Early Drug Development Team |
| Trial Email Address: |
aristocrat@trials.bham.ac.uk
|